The perioperative glycemic control in chronic rhinosinusitis coexisting diabetes.
- Author:
Hongtao ZHEN
1
;
Qixue GAO
;
Liyan PENG
;
Lu PENG
;
Xiaobo LONG
;
Yanling TAO
;
Yonghua CUI
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. zhtlancet@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Chronic Disease;
Diabetes Mellitus, Type 1;
blood;
complications;
drug therapy;
Diabetes Mellitus, Type 2;
blood;
complications;
drug therapy;
Endoscopy;
Female;
Glucose;
metabolism;
Humans;
Hypoglycemic Agents;
therapeutic use;
Male;
Middle Aged;
Perioperative Period;
Retrospective Studies;
Sinusitis;
blood;
complications;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2007;21(2):55-58
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the method of the perioperative blood glucose control in chronic rhinosinusitis coexisting diabetes.
METHOD:Twenty-two cases of chronic rhinosinusitis coexisting diabetes were investigated retrospectively, including one case of type 1 diabetes and 21 cases of type 2 diabetes. The study cohort was divided into two groups, the one was complication group and the other was non-complication group. The patients in complication group were injected insulin to control blood glucose level, and the patients in non-complication group were prescribed oral medicine.
RESULT:Blood glucose levels below 9.0 mmol/L in complication group and below 7.0 mmol/L in non-complication group were both the surgical indication for the patients in this research cohort. Twenty-one cases were completely recovered and one case made progress significantly.
CONCLUSION:The detection of blood and urine glucose levels must be the routine item before the nasal endoscopic surgery. To control blood glucose levels in type 2 diabetes with non-complication, oral medicine is the first choice, in type 1 diabetes and type 2 diabetes with complication, insulin should be first considered.